Re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial: At which gestational ages should magnesium sulphate be given to women at risk of preterm birth?
Mads Langager LarsenLone KrebsGija RackauskaiteChristina Engel Hoei-HansenGorm GreisenPublished in: BJOG : an international journal of obstetrics and gynaecology (2020)
Keyphrases
- preterm birth
- cerebral palsy
- placebo controlled
- gestational age
- low birth weight
- phase iii
- birth weight
- double blind
- study protocol
- phase ii
- clinical trial
- open label
- pregnancy outcomes
- pregnant women
- polycystic ovary syndrome
- weight gain
- randomized controlled trial
- phase ii study
- type diabetes
- cervical cancer screening
- preterm infants
- insulin resistance
- rectal cancer